APA

Panciroli C., Lucente G., Vidal L., Carcereny E., Quiroga V., Pardo J. C., Romeo M., Estival A., Manzano J. L., Pardo B., Velarde J. M., Esteve A. M., Lopez D., Mañes A., Tuset V., Villà S. & Quintero C. B. (20201116). Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Chicago

Panciroli C, Lucente G, Vidal L, Carcereny E, Quiroga V, Pardo J C, Romeo M, Estival A, Manzano J L, Pardo B, Velarde J M, Esteve A M, Lopez D, Mañes A, Tuset V, Villà S and Quintero C B. 20201116. Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Harvard

Panciroli C., Lucente G., Vidal L., Carcereny E., Quiroga V., Pardo J. C., Romeo M., Estival A., Manzano J. L., Pardo B., Velarde J. M., Esteve A. M., Lopez D., Mañes A., Tuset V., Villà S. and Quintero C. B. (20201116). Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

MLA

Panciroli C, Lucente G, Vidal L, Carcereny E, Quiroga V, Pardo J C, Romeo M, Estival A, Manzano J L, Pardo B, Velarde J M, Esteve A M, Lopez D, Mañes A, Tuset V, Villà S and Quintero C B. Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 20201116.